USPTO serial 87091052
XIROMED
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 28, 2021
- Examiner
- HOWARD,PARKER WALDRIP
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with XIROMED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Arturo Perez-Guerrero
Arturo Perez-Guerrero MARCAS ESTADOS UNIDOSP.O. Box 9024163San Juan, PR 00902-4163United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparation for use in treating digestive diseases and disorders, gynecological diseases and disorders, hormonal diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, psychiatric diseases, musculoskeletal system, respiratory system, circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, cholesterol, blood pressure and rheumatic treatments; all of the foregoing excluding pharmaceutical preparations for the treatment and/or management of sleep disorders, narcolepsy, cataplexy, and/or excessive daytime sleepiness (EDS); veterinary preparation for treating digestive diseases and disorders, gynecological diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, musculoskeletal system, respiratory system, circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, cholesterol, blood pressure and rheumatic treatments; all of the foregoing excluding pharmaceutical preparations for the treatment and/or management of sleep disorders, narcolepsy, cataplexy, and/or excessive daytime sleepiness (EDS) | ACTIVE | Mar 26, 2016 |
| 035 | Sales promotion for others, business management assistance, business management consultancy and market research; presentation of goods by any means of communications for retailing purposes; commercial administration of the licensing of the goods and services of others; organisation of exhibitions, trade fairs or congresses for commercial or advertising purposes; all the aforesaid in this class relating to pharmaceutical businesses and for pharmaceutical preparations | ACTIVE | Mar 23, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CHEMO ESPAÑA. S.L.
- Other trademarks owned by CHEMO ESPAÑA. S.L.
- Other trademarks owned by INSUD PHARMA, S.L.U.
- Other trademarks owned by INSUD PHARMA, S.L.U.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named XIROMED
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 9, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 9, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 9, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 28, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 23, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 22, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Nov 9, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 6, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 23, 2021 | IUAF | USE AMENDMENT FILED | — |
| Sep 23, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 14, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 14, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 14, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 14, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 14, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 14, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 20, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 5, 2021 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Mar 5, 2021 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Mar 5, 2021 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jan 16, 2019 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Feb 27, 2017 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jan 27, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 27, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 28, 2016 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 30, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 30, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 10, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 26, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 22, 2016 | ALIE | ASSIGNED TO LIE | — |
| Jul 11, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 11, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 11, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 11, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 11, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 6, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 6, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 5, 2016 | NWAP | NEW APPLICATION ENTERED | — |